EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Christopher W. Ryan, Catherine Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell Meng, Ajjai Shivaram Alva, Sumanta K. Pal, Igor Puzanov, Joseph I. Clark, Toni K. Choueiri, Neeraj Agarwal, Robert Uzzo, Naomi B. Haas, Timothy W. Synold, Melissa Plets, Ulka N. Vaishampayan, Brian M. Shuch, Nicholas J. Vogelzang, Ian M Thompson, Primo “Lucky” N. Lara
Institutions: OHSU Knight Cancer Institute, Fred Hutch Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Columbia University Irving Medical Center, University of California, San Francisco, University of Michigan, U-M Rogel Cancer Center, City Of Hope National Medical Center, City of Hope, Roswell Park Comprehensive Cancer Center, Loyola University Medical Center, Loyola University Chicago, Dana-Farber Cancer Institute, University of Utah, Huntsman Cancer Institute, Fox Chase Cancer Center, Abramson Cancer Center, University of Pennsylvania, University of California, Los Angeles, Comprehensive Cancer Centers of Nevada, Children's Hospital of San Antonio, University of California System
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4293083605